Adams E, Karthaus W, Hoover E, Liu D, Gruet A, Zhang Z, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571:408-412 pubmed 出版商

Kim J, Lee H, Cai F, Ko B, Yang C, Lieu E, et al. The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020;2:1401-1412 pubmed 出版商

Buel G, Chen X, Chari R, O Neill M, Ebelle D, Jenkins C, et al. Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10. Nat Commun. 2020;11:1291 pubmed 出版商

Nagaraja S, Quezada M, Gillespie S, Arzt M, Lennon J, Woo P, et al. Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State. Mol Cell. 2019;76:965-980.e12 pubmed 出版商

Lee E, Wongvipat J, Choi D, Wang P, Lee Y, Zheng D, et al. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance. elife. 2019;8: pubmed 出版商

Hromas R, Kim H, Sidhu G, Williamson E, Jaiswal A, Totterdale T, et al. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells. Breast Cancer Res. 2017;19:122 pubmed 出版商